Calotropis gigantea white (Asclepiadaceae) has been documented as a traditional treatment of diabetes. The aim of this study was to evaluate the antidiabetic activity of chloroform and ethyl acetate extracts from the flower in normal and alloxan-induced diabetic rats. Blood samples were obtained and blood glucose levels were analyzed employing a glucometer at different time intervals on 1st, 4th, 8th and 12th day of the treatment with C. gigantea white extracts compare to glibenclamide (10 mg / kg). From the results, it is revealed that the test chloroform, and ethyl acetate extracts at a dose level 500 mg / kg, showed a significant reduction in blood sugar level day in a progressive manner comparable to glibenclamide. Biochemical parameters, including hemoglobin, urea, creatinine, serum cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were also assessed. Treatment of diabetic rats with the two extracts of this plant restored the elevated biochemical parameters significantly (p<0.05) to the normal level. It also proves the traditional claim with regard to C. gigantea white for its anti-diabetic activity.
INTRODUCTION
Diabetes is a chronic disorder in the metabolism of carbohydrates, proteins, and fat due to absolute or relative deficiency of insulin secretion with/without varying the degree of insulin resistance 1 . Effective blood glucose control is the key to preventing or reversing diabetic complications and improving the quality of life in patients with diabetes 2 . Diabetes also gives rise to various secondary problems such as cataracts, microvascular problems, and neuropathy. These secondary problems commonly arise due to oxidative stress and DNA damage caused in cells by means of free radical generation 3 . Management of diabetes without side effects is still challenging to the medical community. Pharmacological and clinical trials of medicinal plants have shown anti-diabetic effects and repair of β-cells of islets of Langerhans 4 . Many of these medicinal plants and herbs are a potential source of many drugs used in modern medicine, for example, quinine, opium alkaloids, atropine, cardiac glycosides (digitalis) and the popular hypoglycemic drug glucophage (metformin), derived from Galega officinalis 5 . A wide range of plants has been reported in the literature to prevent and treat diabetes.
Calotropis gigantea white (Asclepiadaceae), commonly known as milkweed or swallow-worth, is found chiefly in temples and Wasteland throughout India 6 . The traditional healers suggested that, when using C. gigantea for medication, white flowering should be preferred over purple flowering. It is known for various medicinal properties in the traditional medicinal system and uses to cure a variety of diseases. It has been
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[107] CODEN (USA): JDDTAO reported as a traditional folkloric medicine for treatment of asthma in the Indian literature 7 . Phytochemical studies on Calotropis have afforded several types of compounds such as Cardenolide, triterpenoids, alkaloids, resins, anthocyanins and proteolytic enzymes in latex, flavonoids, tannins, sterol, saponins and cardiac glycosides. Flowers contain terpenes, multi fluorenol, and cyclisadol 8 . Hence, taking into consideration the traditional evaluation and reported activities, the present study was undertaken to test plant C. gigantea white for its antidiabetic activities of the extract on alloxan induced rats as animal model and the effect of the carbohydrate metabolizing enzymes and lipid, as no work is done in this direction and to check possible role of plant in antidiabetic activity.
MATERIALS AND METHODS

Collection and identification of plant material
Calotropis gigantea white, flowers were collected in the month of February -March from the campus of Siva Temple, Thiruvisanallur, Thanjavur India and the plant was identified by Dr. N. Ramakrishnan, Associate Professor and Head, Department of Botany, Government Arts College (Autonomous), Bharathidasan University, Trichirappalli, Tamilnadu, India. A voucher specimen (GACBOT-107) was deposited in the research laboratory, Botany for future reference. The collected fresh flower materials were washed properly and dried in the shade. Dried plant material was subjected to reduction to coarse powdered and stored in airtight container for further use.
Preparation of plant extract
The flowers (500 g) of Calotropis gigantea white were extracted three times with 95% methanol (4 X 500 mL) at room temperature (30 ± 2 °C). Following filtration, the combined methanol extract was evaporated to dryness under reduced pressure to give a crude extract. The crude methanol extract was suspended in hot water (1000 mL) and that was subjected to column chromatography over Silica gel using with chloroform and ethyl acetate, and the solvent recovered by simple distillation. Evaporation of the solvent under reduced pressure gave the crude extract CHCl 3 (39.0 g) and EtOAc (28.0 g) respectively. Each extract was dissolved in distilled water before its administration to the diabetic rats. This was prepared by dissolving 2 g of plant extract in 25 mL 2% Tween -80 / distilled water and normal saline in a falcon tube in a hot water bath with vigorous shaking. The dose of each extract was calculated according to body weight before administration to the diabetic rats.
Experimental animals
Wistar albino rats (200-220 g) of either sex were used for this study and were kept in the animal house at 25 ± 2°C with relative humidity 50-55% along with light and dark cycles of 12 h respectively (6-10 h light, 18-6 h dark). The animals were fed with Standard animal feed (Hindustan Lever Ltd.) and water was applied ad libitum. The animal experiments were carried out in accordance with the guidelines of Committee for the Purpose of Care and Supervision of Experimental 
Experimental design
The animals were divided into six groups each containing six animals.
Group-I: Served as normal control. Control rats received only normal saline.
Group-II: The Second group of rats with diabetes was induced by intraperitoneal injection of alloxan for 2 days.
Group-III: Alloxan treated rats were administered the Glibenclamide (10 mg/ kg) and served as standard.
Group-IV: Alloxan treated rats were administered the chloroform extract of Calotropis gigantea white (250 mg / kg) Group-V: Alloxan treated rats were administered the chloroform extract of Calotropis gigantea white (500 mg / kg) Group-VI: Alloxan treated rats were administered the ethyl acetate extract of Calotropis gigantea white (250mg / kg) Group-VII: Alloxan treated rats were administered the ethyl acetate extract of Calotropis gigantea white (250mg / kg) After the treatment period all the groups of rats were euthanized by anesthesia using chloroform vapor and the rats were sacrificed by decapitation. Then the blood was collected in a tube for analysis.
Acute toxicity studies
The resulting extracts were subjected to acute oral toxicity studies as per revised OECD Organization of Economic Co-operation and Development guidelines (OECD No. 425). The C. gigantea white flower extracts were devoid of any toxicity up to 2000 mg/kg body weight in albino rats (200-220g) of either sex for a single oral dose monitored for 12 days. The optimum conditions for experiments were decided on the basis of pilot experiments carried out using three animals per group. For further experiments, a group of at least six animals was used for individual treatment. Based on exploratory studies, antidiabetic activity was investigated using the methanol, chloroform, and ethyl acetate extracts respectively. The control group received only the vehicle. The groups were observed mortality and behavioral changes during 48 h.
Evaluation of anti-diabetic activity
Before starting the experiment, animals were separated according to their body weight. The animals were injected intraperitoneally with freshly prepared alloxan monohydrate at a concentration of 100 mg/kg in normal saline solution (0.9 w/v% NaCl), appears to be the easiest, most reliable practical method of inducing diabetes mellitus. A volume equivalent to 1 ml of the stock solution was given intraperitoneally after which
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[108] CODEN (USA): JDDTAO the blood glucose levels were measured at regular intervals (i.e., every 6 h) four times daily for three days using digital display glucometer (One touch -Johnson & Johnson Ltd.). Alloxan administration resulted in significant elevation of glucose level and reduction in body weight. Diabetes was confirmed by the elevated blood glucose levels determined at 72 h. Initial blood sample was taken before the oral administration of the standard drug glibenclamide, test extracts at a dose of 300 mg/kg of C. gigantea white. The blood glucose level test was done on the normal, diabetic, and treated diabetic rats were measured at 0, 4, 8 and 12 days after oral administration of glibenclamide and plant extracts.
Biochemical analysis
After blood glucose estimation on day 12, whole blood samples were drawn from the tail vein during the course of the experiment. At the end of the experimental period (12 days), the rats were anesthetized with chloroform following a 12 -hour fast. Blood samples were drawn by cardiac puncture into plain tubes. The blood samples were centrifuged at 3500 rpm for 20 minutes using a refrigerated centrifuge at 4°C (Remi Laboratory Instruments, Mumbai, India). The serum collected was stored at -20°C until needed. Serum albumin was determined using the bromocresol (BCG) green method with an Autopak kit. The total protein present in serum was estimated by the Biuret method 9 using an Autopak kit. Serum was separated and analyzed for serum cholesterol, 10 serum HDL, 11 serum LDL, 12 serum creatinine, 13 serum urea, 14 levels of hemoglobin using the ion exchange resin method 15 with kits purchased from Diotek India Ltd, Mumbai, India, were estimated. To the animals, standard drug glibenclamide tablets (10 mg
Statistical analysis
All the values of body weight, fasting blood sugar, and biochemical estimations were expressed as mean ± standard error of mean (SEM) and analyzed for ANOVA and post hoc Dunnet's t-test. Differences between groups were considered significant at P < 0.05 levels.
RESULTS AND DISCUSSION
Alloxan induced anti diabetic activity
The anti-diabetic effect of the test extracts on the blood glucose levels of diabetic rats is shown in Table 1 . The effect seems to reach the maximum after the 12 th day of treatment and remains constant. Glibenclamide used as standard drug exhibited the highest activity with a final decrease of 87.26 ± 2.68 mg on day 12, followed by ethyl acetate extract at dose of 250 & 500 mg / kg (124.41 ± 2.56 and 104.41 ± 2.69 mg) and chloroform extract at a dose of 250 & 500 mg / kg (131.25 ± 2.64 and 109.25 ± 2.67 mg) respectively. There is no significant change in the blood glucose levels of rats in group I that received normal saline solutions (negative control). Table 2 showed the body weight changes in the normal and experimental animals in each group. The mean body weight of the animals after 12 days of treatment with chloroform and ethyl acetate extract (500 mg / kg) and glibenclamide (10 mg/kg) was 179.29 ± 4.38, 186.82 ± 4.34 , and 198.32 ± 4.33 mg/kg respectively. Values are expressed in Mean ± SD (n=6). There is no significant difference between standard and test drug at P< 0.05 significant level.
Biochemical analysis
The biochemical parameters (Table 3 & 4) such as serum cholesterol, serum LDL, serum urea and serum creatinine levels were significantly decreased and HDL levels were increased by test various extracts of C. gigantea white and glibenclamide. The results also showed the levels of hemoglobin in control and experimental groups of rats. A significant decrease in the level of hemoglobin was observed in diabetic rats (9.56 ± 0.47) when compared to control rats. After treatment with glibenclamide (10 mg/kg) and chloroform and ethyl acetate extracts of C. gigantea white (250 & 500 mg/kg) to diabetic rats resulted (12.91 ± 0.48 and 12.26 ± 0.46, 12.69 ± 0.48 mg) in the restoration of hemoglobin level to near normal (P<0.05). Serum urea and serum creatinine levels were decreased significantly (p<0.05) after the treatment with 500 mg of chloroform, ethyl acetate extracts and glibenclamide (urea: 38.32 ± 2.3; 34.41 ± 2.2; and 32.14 ± 2.4 mg; creatinine: 0.62 ± 0.4; 0.58 ± 0.2; and 0.56 ± 0.2 mg) and the activity was comparable with that of the standard drug glibenclamide (urea: 32.14 ± 2.4; creatinine: 0.56 ± 0.2 mg) respectively. The present investigation showed the level of lipids in normal and tested animals. Administration of the chloroform and ethyl acetate extracts of the flowers of C. gigantea to alloxan monohydrate -diabetic rats protected the alterations of lipid levels. There was a significant increase in total protein content in the treated diabetic rats compared with the diabetic controls. The mean total protein content in rats treated with the test chloroform and ethyl acetate extract at a dose of 500 mg / kg was 6.84 ± 0.84, 6.89 ± 0.85 respectively, which were slightly lower than that the total protein content in rats treated with the glibenclamide at dose of 10 mg / kg (6.98 ± 0.84 mg). There was a significant decrease in the levels of total cholesterol (149. From the results, it is revealed that the test chloroform, and ethyl acetate extracts at a dose level 250 & 500 mg / kg, showed a significant reduction in blood sugar level day in a progressive manner comparable to glibenclamide. The treatment of diabetes with phytomedicine proved much safer than synthetic drugs throughout the world and gained importance in recent years 16 . The mean body weight of the diabetic rats decreased significantly (P < 0.05) compared to diabetic treated rats. The administration of a various extract of C. gigantea white restored these levels significantly towards normal. This may also be due to the protective effect of the extracts in controlling muscle wasting i.e. reversal of gluconeogenesis. Due to insulin deficiency
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[110] CODEN (USA): JDDTAO protein content is decreased in muscular tissue by proteolysis 17 . Alloxan caused body weight reduction, which is reversed by chloroform and ethyl acetate extract at high dose (500 mg/kg) is more effectively than at low dose (250 mg/kg) after 12 days of treatment.
Biochemical parameters indicate that flower extracts of this plant had favorable effects on lipid metabolism of diabetic rats. An increase in the level of hemoglobin in the diabetic control group of rats is due to the presence of a large amount of blood glucose which reacts with hemoglobin to form glycosylated hemoglobin 18 . Administration of alloxan decreases serum albumin levels due to increased non-enzymatic glycosylation of protein 19 . Treatment of diabetic rats with chloroform and ethyl acetate extracts restored albumin to normal levels. On administering at 250 and 500 mg / kg various test extracts from C. gigantea white orally to diabetic rats decreased serum urea and creatinine, more effectively, and could be explained by the regenerative ability of the renal function. Diabetic produces the elevation of urea and creatinine which are considered to be significant markers of renal dysfunction 20 . The diabetic effect of plant extracts was similar to that of glibenclamide and appears to be through inhibition of gluconeogenesis since serum urea was reduced and skeletal muscle mass was increased. The elevated level of serum cholesterol, LDL, and reduced level of HDL possess to be rise of a factor for developing microvascular complication leading atherosclerosis and cardiovascular diseases like coronary heart disease 21 .
The results of the present study are also supported by the earlier reports on the hypoglycemic activity of C. gigantea leaves and flowers (purple color) extract 22 , against alloxan induced diabetes mellitus. In this study, the maximum activity was found in chloroform and ethyl acetate extracts of C. gigantea white flowers have been reported to contain 4-methoxy-3-(methoxymethyl) phenol and 4-methoxy-N2-(5-bromo-2-methoxy benzylideno) benzhydrazide is the major compounds in the both extracts from GC-MS spectrum reported previously 23 . Phenolic compounds were considered as the main contributors responsible for the free radical scavenging activity) of the total hexane extract of many plants 24 attributed the anti-diabetic, anti-inflammatory anti-tumor and anti-proliferative effect of many Labiatae species. Alkaloids, glycosides, carbohydrate, bitter principles, and saponins have similarly been implicated in the antidiabetic activities of a plant 25 . Alloxan destroys insulin-producing pancreatic ß-cells through the formation of reactive oxygen species that cause tissue damage 26 . However, it seems reasonable to suggest that the antioxidant and radical scavenging effects of this plant 23 may play a key role in protecting pancreatic tissues from oxidants including that generated by alloxan. However, the presence of these compounds in C. gigantea extracts could be mediated, at least in part, through activation of these natural products in the in the diabetes treatment have decreased blood glucose levels of diabetic rat and protected the alterations of lipid levels.
CONCLUSION
Our study clearly showed that Calotropis gigantea white caused marked hypoglycemic activity in alloxaninduced diabetic rat model which indicates antidiabetic potentials of the chloroform and ethyl acetate; extracts have beneficial effects on blood glucose levels. Our results support overall in vivo antidiabetic activity of the extracts that may prove to be of clinical importance in improving the management of diabetes. In addition, biochemical investigations have clearly elucidated the mechanism of action and will be helpful this plant extracts as a therapeutic target in diabetes research and the establishment of the exact mechanism(s) of action. The toxic effects and pharmacological activities of these plants should also be elucidated.
